Try our new research platform with insights from 80,000+ expert users

CylancePROTECT vs Intercept X Endpoint (Sophos) comparison

 

Comparison Buyer's Guide

Executive SummaryUpdated on Nov 2, 2025

Review summaries and opinions

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Categories and Ranking

BlackBerry Cylance Cybersec...
Ranking in Endpoint Protection Platform (EPP)
26th
Average Rating
8.0
Reviews Sentiment
4.6
Number of Reviews
44
Ranking in other categories
No ranking in other categories
Intercept X Endpoint
Ranking in Endpoint Protection Platform (EPP)
11th
Average Rating
8.4
Reviews Sentiment
6.8
Number of Reviews
107
Ranking in other categories
Endpoint Detection and Response (EDR) (15th), ZTNA (9th), Managed Detection and Response (MDR) (8th), Extended Detection and Response (XDR) (13th), Ransomware Protection (4th)
 

Mindshare comparison

As of January 2026, in the Endpoint Protection Platform (EPP) category, the mindshare of BlackBerry Cylance Cybersecurity is 1.2%, down from 1.3% compared to the previous year. The mindshare of Intercept X Endpoint is 1.5%, down from 2.0% compared to the previous year. It is calculated based on PeerSpot user engagement data.
Endpoint Protection Platform (EPP) Market Share Distribution
ProductMarket Share (%)
Intercept X Endpoint1.5%
BlackBerry Cylance Cybersecurity1.2%
Other97.3%
Endpoint Protection Platform (EPP)
 

Featured Reviews

Sooraj Makkancherrry - PeerSpot reviewer
Security Operations Manager at Philips
Doesn't have daily updates, which is important for healthcare IT
I face challenges with the exclusion policy - it still scans folders we told it not to, causing issues. When we contact support, they tell us to update the latest agent, but we can't do that immediately due to medical device protocols and validation testing. I wish support would try to understand our issues better instead of giving this standard response. The machine learning feature they use often tells us to upgrade the agent or add things to the exclusion list, which isn't unacceptable. It's a very good and new technology as a tool and antivirus. But sometimes, it doesn't work properly with our medical devices and products, quarantining files it shouldn't even after we add them to exclusions. This is tricky for us.
AM
IT Head at Dee Development
Has struggled to detect major threats but has offered basic protection over time
Intercept X Endpoint could learn from CrowdStrike in terms of overall performance and filtering because performance is most important, especially these days as Windows is getting buggier and buggier, which puts a huge load on the PC, and even with the most advanced CPUs and everything in place, it still lags in performance in so many places, thanks to Windows' clumsy design of these collaboration suites that make it extremely heavy on PC's resources. The interface of Intercept X Endpoint is quite old-fashioned. The Sophos interfaces, including for Intercept X Endpoint, are quite bad actually; to be very honest, even in UTM boxes, they are not great at all. You can hardly see a very small portion of windows while it's creating the firewall rules, and we have been complaining about this for quite some time, but there hasn't been any improvement on those grounds. Intercept X Endpoint's anti-ransomware capabilities failed us during a bad attack, and just because of our own backup policies, we could restore our normal operations; otherwise, if we had to depend on this solution, we would have been long dead because the infection was so bad, it couldn't even detect the infection. Intercept X Endpoint cannot handle zero-day attacks; in my experience, last year, we had this major issue with a malware attack, and it happened just because of our backup policies that we were able to recover without any support from Sophos, which just told us they would charge us some 1 Crore in rupees. Intercept X Endpoint should improve their implementation; things will never be perfect for the new world. This new world is always facing new kinds of attacks and new ways to compromise the system. They need to learn fast, implement fast, and sometimes redesigning the solution is the solution—not just patchwork. There was a time we used to love Sophos because of its fresh design and innovative thought. In my experience, when technical companies are led by MBA professionals, they lose their shine on the technical part and become more dependent on target sales; it turns into a marketing-centric operation that loses the technical focus completely.

Quotes from Members

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Pros

"Endpoints are protected in real-time without the need of a centralized server."
"CylancePROTECT is very stable - we've had no issues with performance and no errors or bugs."
"The platform's most valuable features are the malware detection capabilities."
"The most valuable features are script blocking and macros within Word documents for stopping unwanted applications from running in the background."
"The solution’s AI is its most valuable feature."
"The solution is pretty easy to scale."
"It is a good endpoint solution. It is very easy to manage and detect the threat immediately. It will take the necessary actions."
"CylancePROTECT works on AI technology, is always up to date, and uses very few resources on your devices."
"The solution protects us."
"The initial setup is pretty straightforward."
"There are products that are technically stronger. However, this product has everything in one solution, which makes it a strong endpoint option."
"The most valuable feature is the CryptoGuard in Sophos. In a case of a ransomware attack, this feature comes into action to protect us."
"One of the best use cases involves synchronized security staff, which allows us to manage both the firewall and the anti-virus features from the cloud."
"The most valuable features of Sophos Intercept X are the ease of use and the policy options that are simple to understand. Overall, the protection is good."
"Ransomware protection is the most valuable feature of this solution."
"The key factor that attracted me to Sophos Intercept X was the multi-platform. I have multiple clients that have mixed environments of Mac and Windows. I am able to deliver a standard solution, regardless of the platform."
 

Cons

"The user interface is outdated."
"We would like to see secure integration and multi-factor authentication to be able to access the administration dashboard."
"The stability could be improved."
"I would like to see them fix the alerting system so that the endpoint reporting is a bit more streamlined."
"rom my experience interacting with the primary or the central administrative console, it's quite complex. You would need a fair bit of technical experience to set it up, implement and maintain it. That would be one area for improvement."
"The price for this EPP platform is expensive and could be improved."
"Enhancing the product's detection rates and streamlining the user interface for easier management in daily operations would be beneficial improvements."
"It's a good solution but some features just need to be updated."
"I'm not clear on what features need improvement. Everything is mostly fine."
"The product defends very well on its own but could possibly use enhancement in giving users more controls."
"It would be beneficial if you could expand support for Windows 7 and Windows Server 2008 without charging an additional fee."
"The majority of our systems are MacBooks and their solution release cycle is slow to endorsing or support the MacBook's latest OS or hardware platform. For example, when Sophos macOS Big Sur version 11 was released, it took them a while to support this version of OS. A similar situation occurred when the MacBook M1 hardware CPU was released. They have not fully supported the native M1 CPU to this day. They need to speed up the solutions release cycle."
"Sophos needs to create a YouTube channel with educational material for technicians or engineers."
"The deployment part needs to be improved."
"The product’s DDoS and AI features must be improved."
"The EDR could be improved, and perhaps the User Interface."
 

Pricing and Cost Advice

"The price is reasonable for us at the moment. I rate the overall solution an eight out of ten."
"​Shop around for sure and be assured the price you pay will be close to other solutions available, but even at a slight mark-up from the other solutions, you are getting real endpoint protection versus nothing more than a cheap security blanket that might keep you warm at night."
"We would just add more if there are new users, but right now you just need one license for per user."
"It is expensive, but not unreasonable."
"The tool is not that expensive."
"Currently, we have competitive pricing for Cylance, which is affordable enough to consider."
"The product cost is about $5, per user, per month."
"The license price for this solution could be better. It's on the expensive side."
"Its cost is good."
"You are able to purchase more licenses for the number of devices or servers that you require. There are many other features available but our license does not include them, such as XDR, which is endpoint detection and response. We have not explored the new features as of yet but plan to in the coming future."
"The cost of Sophos Intercept X is reasonable."
"The price of the product is okay, in my opinion. The tool's cost per user and per annum basis is around INR 700 to 800."
"It's not bad, but compared to competitors, it's a little bit on the high side. The price could be more competitive."
"The price of Sophos Intercept X is expensive. The license is paid on an annual basis. There are extra features that can be added depending on the endpoints. The solution is priced twice as much as the Comodo solution."
"It was fairly and reasonably priced."
"The price of this solution is reasonable."
report
Use our free recommendation engine to learn which Endpoint Protection Platform (EPP) solutions are best for your needs.
879,899 professionals have used our research since 2012.
 

Top Industries

By visitors reading reviews
Manufacturing Company
10%
Computer Software Company
9%
Government
7%
Comms Service Provider
6%
Computer Software Company
14%
Comms Service Provider
8%
Manufacturing Company
8%
Financial Services Firm
5%
 

Company Size

By reviewers
Large Enterprise
Midsize Enterprise
Small Business
By reviewers
Company SizeCount
Small Business33
Midsize Enterprise5
Large Enterprise13
By reviewers
Company SizeCount
Small Business72
Midsize Enterprise22
Large Enterprise22
 

Questions from the Community

What do you like most about Blackberry Protect?
It is a good endpoint solution. It is very easy to manage and detect the threat immediately. It will take the necessary actions.
What is your experience regarding pricing and costs for Blackberry Protect?
The price is reasonable for us at the moment. I rate the overall solution an eight out of ten.
What needs improvement with Blackberry Protect?
I face challenges with the exclusion policy - it still scans folders we told it not to, causing issues. When we contact support, they tell us to update the latest agent, but we can't do that immedi...
How does Crodwstrike Falcon compare with Sophos Intercept X?
I like that Crowdstrike Falcon allows me to easily correlate data between my firewalls. Its detection and machine learning are very valuable features. Crowdstrike Falcon also successfully prevents ...
What is your experience regarding pricing and costs for Sophos Intercept X?
Pricing of Sophos, including for Intercept X Endpoint, is okay; definitely, it is okay. We pay for Sophos on a product by product basis, whatever we buy, whatever we use.
 

Also Known As

Blackberry Protect
Sophos Intercept X
 

Overview

 

Sample Customers

Panasonic, Noble Energy, Apria Healthcare Group Inc., Charles River Laboratories, Rovi Corporation, Toyota, Kiewit
Flexible Systems
Find out what your peers are saying about BlackBerry Cylance Cybersecurity vs. Intercept X Endpoint and other solutions. Updated: December 2025.
879,899 professionals have used our research since 2012.